Literature DB >> 25487024

CHIP: a co-chaperone for degradation by the proteasome.

Adrienne L Edkins1.   

Abstract

Protein homeostasis relies on a balance between protein folding and protein degradation. Molecular chaperones like Hsp70 and Hsp90 fulfil well-defined roles in protein folding and conformational stability via ATP dependent reaction cycles. These folding cycles are controlled by associations with a cohort of non-client protein co-chaperones, such as Hop, p23 and Aha1. Pro-folding co-chaperones facilitate the transit of the client protein through the chaperone mediated folding process. However, chaperones are also involved in ubiquitin-mediated proteasomal degradation of client proteins. Similar to folding complexes, the ability of chaperones to mediate protein degradation is regulated by co-chaperones, such as the C terminal Hsp70 binding protein (CHIP). CHIP binds to Hsp70 and Hsp90 chaperones through its tetratricopeptide repeat (TPR) domain and functions as an E3 ubiquitin ligase using a modified RING finger domain (U-box). This unique combination of domains effectively allows CHIP to network chaperone complexes to the ubiquitin-proteasome system. This chapter reviews the current understanding of CHIP as a co-chaperone that switches Hsp70/Hsp90 chaperone complexes from protein folding to protein degradation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25487024     DOI: 10.1007/978-3-319-11731-7_11

Source DB:  PubMed          Journal:  Subcell Biochem        ISSN: 0306-0225


  40 in total

Review 1.  Targeting Hsp70 facilitated protein quality control for treatment of polyglutamine diseases.

Authors:  Amanda K Davis; William B Pratt; Andrew P Lieberman; Yoichi Osawa
Journal:  Cell Mol Life Sci       Date:  2019-09-24       Impact factor: 9.261

2.  Parkinson's disease-associated receptor GPR37 is an ER chaperone for LRP6.

Authors:  Birgit S Berger; Sergio P Acebron; Jessica Herbst; Stefan Koch; Christof Niehrs
Journal:  EMBO Rep       Date:  2017-03-24       Impact factor: 8.807

Review 3.  It's not magic - Hsp90 and its effects on genetic and epigenetic variation.

Authors:  Rebecca A Zabinsky; Grace Alexandria Mason; Christine Queitsch; Daniel F Jarosz
Journal:  Semin Cell Dev Biol       Date:  2018-06-06       Impact factor: 7.727

4.  [Mechanism of heat shock protein 90 for regulating 26S proteasome in hyperthermia].

Authors:  Qing-Rong Ma; Pei-Zhi Yu; Fan Zhang; Yu-Qi Li; Shu Yang; Xian-Yi Mo; Kai-Lan Mo; Ying Ding; Si-Ze Chen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-04-20

Review 5.  Tau Protein Squired by Molecular Chaperones During Alzheimer's Disease.

Authors:  Nalini Vijay Gorantla; Subashchandrabose Chinnathambi
Journal:  J Mol Neurosci       Date:  2018-09-28       Impact factor: 3.444

6.  Regulation of the Ysh1 endonuclease of the mRNA cleavage/polyadenylation complex by ubiquitin-mediated degradation.

Authors:  Susan D Lee; Hui-Yun Liu; Joel H Graber; Daniel Heller-Trulli; Katarzyna Kaczmarek Michaels; Juan Francisco Cerezo; Claire L Moore
Journal:  RNA Biol       Date:  2020-02-12       Impact factor: 4.652

Review 7.  Hepatic cytochromes P450: structural degrons and barcodes, posttranslational modifications and cellular adapters in the ERAD-endgame.

Authors:  Sung-Mi Kim; YongQiang Wang; Noushin Nabavi; Yi Liu; Maria Almira Correia
Journal:  Drug Metab Rev       Date:  2016-06-20       Impact factor: 4.518

8.  DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathway.

Authors:  Alejandro Parrales; Atul Ranjan; Swathi V Iyer; Subhash Padhye; Scott J Weir; Anuradha Roy; Tomoo Iwakuma
Journal:  Nat Cell Biol       Date:  2016-10-24       Impact factor: 28.824

Review 9.  The E3 ubiquitin ligase CHIP in normal cell function and in disease conditions.

Authors:  Tingyu Wang; Wenbo Wang; Qishan Wang; Rong Xie; Alan Landay; Di Chen
Journal:  Ann N Y Acad Sci       Date:  2019-08-15       Impact factor: 5.691

Review 10.  Modulation of Molecular Chaperones in Huntington's Disease and Other Polyglutamine Disorders.

Authors:  Sara D Reis; Brígida R Pinho; Jorge M A Oliveira
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.